A 55-year-old entrepreneur, with a family history of ischemic heart disease, felt he was sitting on a ticking time bomb as he had hypertension and Type 2 diabetes. When he…
(Reuters) -Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials. The oral drug is designed to mimic the appetite-suppressing GLP-1 hormone…
Oral semaglutide reduces craving and improves metabolic health in patients with type 2 diabetes: Research We use cookies to analyse, advertise, and to improve our site. By continuing to use…
In this week’s issue of The Savvy Diabetic: 1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased…
This study was published in the science journal BMJ Open and is based on national registration data. The study includes more than 800,000 individuals, making it the biggest ever to…
Happy New Year everyone! Or maybe I should say, “Happy Now Here” as someone said. The key is to focus on the present moment, not what will happen next year.…
Introduction Diabetes mellitus (DM) is defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both (1). In 2014, the global…